DSM Q2 2016 Results

HEERLEN, the Netherlands, August 2, 2016

Highlights

• DSM reports a second consecutive strong quarter in 2016
• Group net sales up at €1,994 million, with 5% organic growth, and EBITDA up 18%
• Nutrition: organic sales growth of 9%, EBITDA up 14%
• Materials: volumes up 5%, EBITDA up 10%
• H1 Group ROCE: improved to 10.5% (H1 2015: 7.4%) driven by higher EBIT
• Interim dividend of €0.55 per ordinary share
• Outlook revised upward

Key figures and indicators (continuing operations)

   
    in EUR million      Q2 2016 Q2 2015   % Change Volume Price/mix   FX Other
    Sales                 1,994   1,965         1%     6%       -1%  -4%    0%
    Nutrition             1,295   1,247         4%     7%        2%  -5%    0%
    Materials               640     664        -4%     5%       -7%  -2%
    EBITDA                  328     279        18%
    Nutrition               237     208        14%
    Materials               117     106        10%
    ROCE (%) (1)           10.5     7.4

⁽¹⁾ January until June

CEO statement

Feike Sijbesma, CEO/Chairman of the DSM Managing Board, commented: "Our positive momentum from Q1 continued and we are pleased to deliver another strong quarter. This was driven by good growth across our businesses and steady progress in our operations. Furthermore, we remain on track with our ambitious group-wide improvement and cost saving programs.

Materials performed particularly well, with good volume growth, notably in specialties, and a strong margin performance. This was supported by a favorable product mix, continued low input costs, and proactive margin management. In Nutrition, animal nutrition delivered high growth, benefitting in part from a favorable prior year comparison. We were also pleased with the continued progress in human nutrition, which delivered solid growth in line with our medium-term plans to outgrow the market.